These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28558827)

  • 1. Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.
    Tseng HW; Glant TT; Brown MA; Kenna TJ; Thomas GP; Pettit AR
    BMC Musculoskelet Disord; 2017 May; 18(1):228. PubMed ID: 28558827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.
    Tseng HW; Pitt ME; Glant TT; McRae AF; Kenna TJ; Brown MA; Pettit AR; Thomas GP
    Arthritis Res Ther; 2016 Jan; 18():35. PubMed ID: 26831337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study on an autoimmune murine model of ankylosing spondylitis.
    Bárdos T; Szabó Z; Czipri M; Vermes C; Tunyogi-Csapó M; Urban RM; Mikecz K; Glant TT
    Ann Rheum Dis; 2005 Jul; 64(7):981-7. PubMed ID: 15640265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors.
    Haynes KR; Pettit AR; Duan R; Tseng HW; Glant TT; Brown MA; Thomas GP
    Arthritis Res Ther; 2012 Nov; 14(6):R253. PubMed ID: 23171658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF-α therapy alters the gut microbiota in proteoglycan-induced ankylosing spondylitis in mice.
    Liu B; Yang L; Cui Z; Zheng J; Huang J; Zhao Q; Su Z; Wang M; Zhang W; Liu J; Wang T; Li Q; Lu H
    Microbiologyopen; 2019 Dec; 8(12):e927. PubMed ID: 31556231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of preclinical efficacy of human umbilical cord mesenchymal stem cells in ankylosing spondylitis.
    Shen D; Wang Z; Wang H; Zhu H; Jiang C; Xie F; Zhang H; Lv Q; Liu Q; Qi N; Wang H
    Front Immunol; 2023; 14():1153927. PubMed ID: 37063838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.
    Haynes KR; Tseng HW; Kneissel M; Glant TT; Brown MA; Thomas GP
    BMC Musculoskelet Disord; 2015 Nov; 16():368. PubMed ID: 26612313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice.
    Shen J; Yang L; You K; Chen T; Su Z; Cui Z; Wang M; Zhang W; Liu B; Zhou K; Lu H
    Front Immunol; 2022; 13():762580. PubMed ID: 35185872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
    van der Weijden MA; van Denderen JC; Lems WF; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
    J Rheumatol; 2016 Apr; 43(4):758-64. PubMed ID: 26879348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis.
    Cui Y; Xiao Z; Shuxia W; Zhenjun Z; Hengguo Z; Liangyi F; Weicheng G; Li L; Guangfeng Z; Yunzhen S; Guangfu D
    Scand J Rheumatol; 2010 May; 39(3):229-32. PubMed ID: 20109079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease.
    Glant TT; Bárdos T; Vermes C; Chandrasekaran R; Valdéz JC; Otto JM; Gerard D; Velins S; Lovász G; Zhang J; Mikecz K; Finnegan A
    Arthritis Rheum; 2001 Mar; 44(3):682-92. PubMed ID: 11263784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs.
    Poddubnyy D; Song IH; Sieper J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S148-51. PubMed ID: 19822063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
    Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
    J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior uveitis accompanies joint disease in a murine model resembling ankylosing spondylitis.
    Rosenzweig HL; Martin TM; Planck SR; Jann MM; Smith JR; Glant TT; van Eden W; Davey MP; Rosenbaum JT
    Ophthalmic Res; 2008; 40(3-4):189-92. PubMed ID: 18421237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.
    Farkas B; Boldizsar F; Tarjanyi O; Laszlo A; Lin SM; Hutas G; Tryniszewska B; Mangold A; Nagyeri G; Rosenzweig HL; Finnegan A; Mikecz K; Glant TT
    Arthritis Res Ther; 2009; 11(1):R21. PubMed ID: 19220900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice.
    Yang L; Liu B; Zheng J; Huang J; Zhao Q; Liu J; Su Z; Wang M; Cui Z; Wang T; Zhang W; Li Q; Lu H
    Front Cell Infect Microbiol; 2019; 9():44. PubMed ID: 30886835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Complement Retards Ankylosing Spondylitis Progression.
    Yang C; Ding P; Wang Q; Zhang L; Zhang X; Zhao J; Xu E; Wang N; Chen J; Yang G; Hu W; Zhou X
    Sci Rep; 2016 Oct; 6():34643. PubMed ID: 27698377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can structural damage be prevented in ankylosing spondylitis?
    Sieper J
    Curr Opin Rheumatol; 2009 Jul; 21(4):335-9. PubMed ID: 19424070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab in severe active ankylosing spondylitis with spinal ankylosis.
    Cheung PP; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
    Intern Med J; 2008 Jun; 38(6):396-401. PubMed ID: 18336538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.